| A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK- | Phase III | rekrutiert |
| A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibros | Phase III | rekrutiert |
| A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesit | Phase III | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Non-interventional, Prospective Study With Benralizumab | — | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD | Phase III | rekrutiert |
| A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treate | — | rekrutiert |
| A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in P | Phase III | rekrutiert |
| A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) | Phase III | rekrutiert |
| A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal S | Phase III | rekrutiert |
| A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men | Phase III | rekrutiert |
| A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cance | Phase III | rekrutiert |
| A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or L | Phase II | rekrutiert |
| A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NP | Phase I / Phase II | rekrutiert |
| A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab | Phase III | rekrutiert |
| A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract | Phase III | rekrutiert |
| A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Canc | Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Parti | Phase III | rekrutiert |
| A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-M | Phase III | rekrutiert |
| A Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Ey | ohne Phasenangabe | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared | Phase III | rekrutiert |
| A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standar | Phase III | rekrutiert |
| A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Fa | Phase III | rekrutiert |
| AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple My | Phase I / Phase II | rekrutiert |
| AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate | Phase III | rekrutiert |
| Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL | Phase III | rekrutiert |
| Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At | Phase II | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients | — | rekrutiert |
| An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in | Phase III | rekrutiert |
| Assessing AI-Supported Fracture Detection in Emergency Care Units | ohne Phasenangabe | rekrutiert |
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | — | rekrutiert |
| CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting | — | rekrutiert |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | — | rekrutiert |
| Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Loca | Phase IV | rekrutiert |
| Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute My | Phase I / Phase II | rekrutiert |
| Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Ol | Phase II | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Re | Phase IV | rekrutiert |
| Digital Assessment of Real-World Walking Activity in Pulmonary Hypertension: A Prospective Multi | — | rekrutiert |
| Digital Dementia Registry Bavaria (digiDEM Bayern): a Multicentre, Prospective, Longitudinal Reg | — | rekrutiert |
| EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagl | Phase III | rekrutiert |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in Peop | Phase III | rekrutiert |
| Early Catheter-directed Treatment of High Risk Pulmonary Embolism | ohne Phasenangabe | rekrutiert |
| Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA) | Phase III | rekrutiert |
| European Aortic Data Collection Project | — | rekrutiert |
| European Disease Registry on Retinopathy of Prematurity (ROP) | — | rekrutiert |
| Exploratory Investigation of the Acceptance and Utility of 14-day Trial Periods and Application- | ohne Phasenangabe | rekrutiert |
| Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk | ohne Phasenangabe | rekrutiert |
| GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological | — | rekrutiert |
| GISAR German Interdisciplinary Sarcoma Registry | — | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors | Phase I / Phase II | rekrutiert |
| Impact of Implementation Strategies on Lp(a) Testing in Secondary Care Settings | — | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multi | Phase III | rekrutiert |
| Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection | — | rekrutiert |
| Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE | — | rekrutiert |
| NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometr | — | rekrutiert |
| Neurovascular Product Surveillance Registry | — | rekrutiert |
| One-Stop manaGemEnT For A Swift Initiation of Endovascular Therapy | ohne Phasenangabe | rekrutiert |
| PROCARE - PROstate Cancer Real World Evidence Registry | — | rekrutiert |
| PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and | — | rekrutiert |
| Pan Tumor Rollover Study | Phase II | rekrutiert |
| Perioperative Management Evaluation in Patients With CIED | — | rekrutiert |
| Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic | Phase II | rekrutiert |
| Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothel | Phase II / Phase III | rekrutiert |
| Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenal | Phase III | rekrutiert |
| Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanc | Phase III | rekrutiert |
| Post-Market BTVA Registry | — | rekrutiert |
| Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - POR | Phase III | rekrutiert |
| Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectio | Phase II | rekrutiert |
| ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast C | Phase III | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Phase II | rekrutiert |
| Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer | — | rekrutiert |
| Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years Wi | — | rekrutiert |
| Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Pro | — | rekrutiert |
| Risk Factors for Neuroendocrine Neoplasms | — | rekrutiert |
| STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease | Phase III | rekrutiert |
| Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone i | Phase III | rekrutiert |
| Safe and Timely Antithrombotic Removal (STAR) Registry | — | rekrutiert |
| Safety and Efficacy Evaluation of the iNstroke 4F Thromboaspiration Catheter in Patients With Ac | ohne Phasenangabe | rekrutiert |
| Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for P | Phase III | rekrutiert |
| Shockwave™Peripheral Intravascular Lithotripsy Balloon for Advanced Endovascular Aortic Repair | — | rekrutiert |
| SteamOne - Prospective Database for Rezum Water Vapor Therapy of the Prostate | — | rekrutiert |
| Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants W | Phase I / Phase II | rekrutiert |
| Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Wh | Phase III | rekrutiert |
| Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resect | Phase III | rekrutiert |
| Targeting Real World Usage In Stroke Treatment | — | rekrutiert |
| The DefiPace Study | — | rekrutiert |
| The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associate | ohne Phasenangabe | rekrutiert |
| Therapy Optimisation for the Treatment of Hairy Cell Leukemia | Phase II / Phase III | rekrutiert |
| Transfer Effects of Stationary Bicycle Perturbation Training on Older Adults' Cycling Skills | ohne Phasenangabe | rekrutiert |
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM AL | Phase III | rekrutiert |
| Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therap | Phase IV | rekrutiert |
| Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed | Phase II | rekrutiert |